A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

NCT05785468 · clinicaltrials.gov ↗

UNKNOWN

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: Caplacizumab

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS